Αρχειοθήκη ιστολογίου

Παρασκευή 13 Απριλίου 2018

Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer

Laethem, J-LV; Riess, H; Jassem, J; Haas, M; Martens, UM; Weekes, C; Peeters, M; ... Childs, BH; + view all Laethem, J-LV; Riess, H; Jassem, J; Haas, M; Martens, UM; Weekes, C; Peeters, M; Ross, P; Bridgewater, J; Melichar, B; Cascinu, S; Saramak, P; Michl, P; Van Brummelen, D; Zaniboni, A; Schmiegel, W; Dueland, S; Giurescu, M; Garosi, VL; Roth, K; Schulz, A; Seidel, H; Rajagopalan, P; Teufel, M; Childs, BH; - view fewer (2016) Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer. Targeted Oncology , 12 (1) pp. 97-109. 10.1007/s11523-016-0469-y . Green open access

https://ift.tt/2EIMMA7

Αναρτήθηκε από στις

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Εγγραφή σε: Σχόλια ανάρτησης (Atom)